Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
The mRNA for the Duffy blood group antigen, the erythrocyte receptor for the Plasmodium vivax malaria parasite, has recently been cloned and shown to encode a widely expressed chemokine receptor. Here, we show that the Duffy antigen/chemokine receptor gene (DARC) is composed of a single exon and that most Duffy-negative blacks carry a silent FY*B allele with a single T to C substitution at nucleotide -46. This mutation impairs the promoter activity in erythroid cells by disrupting a binding site for the GATA1 erythroid transcription factor. With the recent characterization of the FY*A and FY*B alleles, these findings provide the molecular basis of the Duffy blood group system and an explanation for the erythroid-specific repression of the DARC gene in Duffy-negative individuals.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“DARC is an atypical chemokine receptor and the antigen of the Duffy (Fy) blood group system (Tournamille et al., 1995; Tournamille et al., 1998; Wasniowska and Hadley, 1994).”
From Staphylococcus aureus Targets the Duffy Antigen Receptor for Chemokines (DARC) to Lyse Erythrocytes (2015) · cites this paper as Tournamille et al., 1995
In the citing paper
“A substantial part of the human population carries a homozygous mutation (FY*AES or FY*BES alleles for erythrocyte silent) in the erythroid-specific promoter of the FY gene, resulting in a lack of expression of the receptor on erythrocytes (Fya−/b− phenotype) but not in non-erythroid tissues (Tournamille et al., 1995; Zimmerman et al., 1999).”
From Staphylococcus aureus Targets the Duffy Antigen Receptor for Chemokines (DARC) to Lyse Erythrocytes (2015) · cites this paper as Tournamille et al., 1995
Citations
Cites
Luckow, B., & Schütz, G. (1987) · Nucleic Acids Research · doi:10.1093/nar/15.13.5490 · Cited by 1,701
MODEL SYSTEMS FOR THE STUDY OF SEVEN-TRANSMEMBRANE-SEGMENT RECEPTORS
Dohlman, H. G., Thorner, J., Caron, M. G., & Lefkowitz, R. J. (1991) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.60.070191.003253 · Cited by 1,379
The Resistance Factor to Plasmodium vivax in Blacks: The Duffy-Blood-Group Genotype,FyFy
Miller, L. H., Mason, S. J., Clyde, D. F., & McGinniss, M. H. (1976) · New England Journal of Medicine · doi:10.1056/nejm197608052950602 · Cited by 1,260
Race, R. R., & Sanger, R. A. (1962) · Medical Entomology and Zoology · Cited by 1,162
Compilation of vertebrate-encoded transcription factors
Faisst, S., & Meyer, S. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.1.3 · Cited by 914
GATA-binding transcription factors in hematopoietic cells
Orkin, S. (1992) · Blood · doi:10.1182/blood.v80.3.575.575 · Cited by 884
Erythrocyte Receptors for ( Plasmodium Knowlesi ) Malaria: Duffy Blood Group Determinants
Miller, L. H., Mason, S. J., Dvorak, J. A., McGinniss, M. H., & Rothman, I. K. (1975) · Science · doi:10.1126/science.1145213 · Cited by 610
Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin.
Darbonne, W. C., Rice, G. C., Mohler, M. A., Apple, T., Hébert, C. A., Valente, A. J., & Baker, J. B. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115442 · Cited by 452
Globin gene regulation and switching: Circa 1990
Orkin, S. H. (1990) · Cell · doi:10.1016/0092-8674(90)90133-y · Cited by 442
Chitnis, C. E., & Miller, L. H. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.2.497 · Cited by 426
Research works printed but not linked: 1
- Toumamilte, C., Le Van Kim, C., Gane, P., Cartron, J.P. & Colin, Y. Molecular basis and PCR-DNA typing of the Pya/Pyb blood group polymorphism. Hum. Genet. 85, 407–410 (1995).
Cited by
Items 301–400 of 742
Maestre, A., Muskus, C., Duque, V., Agudelo, O. M., Liu, P., Takagi, A., Ntumngia, F. B., Adams, J. H., Sim, K. L., Hoffman, S. L., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011437 · Cited by 32
“People with mutations in the DARC promoter region that abolish DARC expression (FY*Bnull/FY*Bnull or FY*O) exhibit a Duffy-negative phenotype (Fy2) [28,29,30].”
BackgroundCoevolutionary Genetics of Plasmodium Malaria Parasites and Their Human Hosts
Evans, A. G., & Wellems, T. E. (2002) · Integrative and Comparative Biology · doi:10.1093/icb/42.2.401 · Cited by 40
“In these individuals, expression of the gene is blocked only in developing erythrocytes by a mutation of the promoter region that disrupts binding of the GATA1 erythroid transcription factor (Tournamille et al., 1995).”
Applications of molecular biology techniques to transfusion medicine
Reid, M. E., Rios, M., & Yazdanbakhsh, K. (2000) · Seminars in Hematology · doi:10.1016/s0037-1963(00)90041-6 · Cited by 38
Oboh, M. A., Singh, U. S., Ndiaye, D., Badiane, A. S., Ali, A., Bharti, P. K., & Das, A. (2020) · Malaria Journal · doi:10.1186/s12936-020-03301-w · Cited by 30
“DARC which is located on chromosome 1 has two exons and a single nucleotide substitution from a thymine (T) to a cytosine (C) upstream of the promoter region that nullifies the expression on RBCs ultimately resulting in the FYO* allele [25].”
BackgroundBlood group genotyping by high‐throughput DNA analysis applied to 356 reagent red blood cell samples
Kappler‐Gratias, S., Peyrard, T., Beolet, M., Amiranoff, D., Ménanteau, C., Dubeaux, I., Rouger, P., Cartron, J., Pennec, P. L., & Pham, B. (2010) · Transfusion · doi:10.1111/j.1537-2995.2010.02802.x · Cited by 32
Self-citationSero- and molecular typing of Duffy blood group in Southeast Asians and Oceanians.
Shimizu, Y., Ao, H., Soemantri, A., Tiwawech, D., Settheetham‐Ishida, W., Ow, K., Kimura, M., Nishioka, T., & Ishida, T. (2000) · PubMed · Cited by 31
The role played by natural selection on Mendelian traits in humans
Quintana‐Murci, L., & Barreiro, L. B. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05856.x · Cited by 35
Genotyping Applications for Transplantation and Transfusion Management: The Emory Experience
Fasano, R. M., Sullivan, H. C., Bray, R. A., Gebel, H. M., Meyer, E., Winkler, A. M., Josephson, C. D., Stowell, S. R., Duncan, A., & Roback, J. D. (2017) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2016-0277-sa · Cited by 28
“86,87 RBC GENOTYPING AS AN AID TO PROVIDING EXTENDED MATCHED BLOOD FOR PATIENTS WITH HEMOGLOBINOPATHIES Although many transfusion services provide RBCs phenotypically matched for Rh (C/c, E/e) and K (limited match), some also endorse prophylactic, extended antigen matching to include the Duffy (Fy…”
Distribution of Duffy Phenotypes among Plasmodium vivax Infections in Sudan
Albsheer, M. M. A., Pestana, K., Ahmed, S., Elfaki, M. M. A., Gamil, E., Ahmed, S., Ibrahim, M. E., Musa, A. M., Lo, E., & Hamid, M. M. A. (2019) · Genes · doi:10.3390/genes10060437 · Cited by 30
“The silent FYBES allele results from a mutation in the GATA box motif of the FYB promoter (−33T→C) which is known to disrupt the binding of erythroid transcription factor to GATA-1, leading to a reduced Duffy antigen expression [11].”
BackgroundMa, X., Ruan, G., Wang, Y., Li, Q., Zhu, P., Qin, Y., Li, J., Liu, Y., Ma, D., & Zhao, H. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0039 · Cited by 30
High-resolution melting analysis for genotyping Duffy, Kidd and Diego blood group antigens
Tanaka, M., Takahahi, J., Hirayama, F., & Tani, Y. (2010) · Legal Medicine · doi:10.1016/j.legalmed.2010.08.004 · Cited by 30
Sampath, S., Carrico, C., Janes, J. H., Gurumoorthy, S., Gibson, C., Melcher, M., Chitnis, C. E., Wang, R., Schief, W. R., & Smith, J. D. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003420 · Cited by 33
“vivax infection [2] and the DARCnull phenotype has independently arisen in different human populations [3,4].”
BackgroundTumor–endothelial cell interactions: Therapeutic potential
Iiizumi, M., Mohinta, S., Bandyopadhyay, S., & Watabe, K. (2007) · Microvascular Research · doi:10.1016/j.mvr.2007.04.002 · Cited by 33
Barbarani, G., Fugazza, C., Strouboulis, J., & Ronchi, A. E. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00091 · Cited by 27
Functional impact of a single-nucleotide polymorphism in the OPRD1 promoter region
Zhang, H., Gelernter, J. E., Gruen, J. R., Kranzler, H. R., Herman, A. I., & Simen, A. A. (2010) · Journal of Human Genetics · doi:10.1038/jhg.2010.22 · Cited by 29
Storti-Melo, L. M., Souza-Neiras, W. C., Cassiano, G. C., Joazeiro, A. C. P., Fontes, C. J. F., Bonini-Domingos, C. R., Couto, Á. A. R. D., Póvoa, M. M., de Mattos, L. C., Cavasini, C. E., et al. (2008) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/j.trstmh.2008.07.018 · Cited by 29
Duffy blood group system and the malaria adaptation process in humans
de Carvalho, G. B., & de Carvalho, G. B. (2011) · Revista Brasileira de Hematologia e Hemoterapia · doi:10.5581/v33n1a16 · Cited by 29
DNA from urine sediment or buccal cells can be used for blood group molecular genotyping
Rios, M., Cash, K. L., Strupp, A., Uehlinger, J., & Reid, A. (1999) · Immunohematology · doi:10.21307/immunohematology-2019-614 · Cited by 28
Martini, R. N., Chen, Y., Jenkins, B. D., Elhussin, I. A., Cheng, E., Hoda, S. A., Ginter, P. S., Hanover, J., Zeidan, R., Oppong, J. K., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-88613-w · Cited by 27
Analysis for genotyping Duffy blood group in inhabitants of Sudan, the Fourth Cataract of the Nile
Kempińska‐Podhorodecka, A., Knap, O., Drozd, A., Kaczmarczyk, M., Parafiniuk, M., Parczewski, M., & Ciechanowicz, A. (2012) · Malaria Journal · doi:10.1186/1475-2875-11-115 · Cited by 28
“glycine in FY*A and aspartic acid in FY*B) [5-9] and point mutation at position T-33°C (previously described as T-46°C) in GATA box responsible for the FY*A (ES = erythrocyte silent) and the FY*B alleles (common African allele) [3,10-16].”
Chatterjee, N. S., Rubin, S. A., & Said, H. M. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.280.3.c548 · Cited by 28
“The existence of GATA-1 binding sites in P1 of the SMVT gene is in line with our previous observations of tissue-specific expression of this gene (5), as these sites are known to be involved in tissue-specific expression of other genes (8, 11, 12, 31).”
ResultCorrelation between ‘ ACKR 1/ DARC null’ polymorphism and benign neutropenia in Yemenite Jews
Rappoport, N., Simon, A. J., Lev, A., Yacobi, M., Kaplinsky, C., Weingarten, M., Somech, R., Amariglio, N., & Rechavi, G. (2015) · British Journal of Haematology · doi:10.1111/bjh.13345 · Cited by 27
“…antigen expression due to the disruption of the GATA1 erythroid transcription factor binding site, whereas the heterozygous state (T/C) and the wild type state (T/T) enable the expression of the Duffy molecule in red blood cells (FY+) (Tournamille et al, 1995; Nalls et al, 2008; Reich et al, 2009).”
BackgroundPlasmodium vivax Infections in Duffy-Negative Individuals in the Democratic Republic of the Congo
Brazeau, N. F., Whitesell, A., Doctor, S. M., Keeler, C., Mwandagalirwa, M. K., Tshefu, A. K., Likwela, J. L., Juliano, J. J., & Meshnick, S. R. (2018) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.18-0277 · Cited by 27
Unambiguous determination of Plasmodium vivax reticulocyte invasion by flow cytometry
Cho, J.-S., Russell, B., Kosasaivee, V., Zhang, R., Colin, Y., Bertrand, O., Chandramohanadas, R., Chu, C. S., Nosten, F. H., Rénia, L., et al. (2015) · International Journal for Parasitology · doi:10.1016/j.ijpara.2015.08.003 · Cited by 26
Self-citationYeh, C.-C., Chang, C., Twu, Y., Chu, C., Liu, B.-S., Huang, J.-T., Hung, S., Chan, Y., Tsai, Y.-J., Lin, S., et al. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018018879 · Cited by 26
“In addition, disruption of a GATA1 motif by a genetic variant (rs2814778) has been identified in the FY (ACKR1) gene promoter region of Africans with the Duffy-negative phenotype.(29) This disruption abolishes the expression of the Duffy blood group antigens on RBCs; as a consequence, this confers resistance to invasi…”
BackgroundQuiver, M. H., & Lachance, J. (2021) · Human Genetics and Genomics Advances · doi:10.1016/j.xhgg.2021.100083 · Cited by 31
“rs2814778 is in the promoter of theDARC gene, and the C allele at this regulatory locus confers a null phenotype.(72) DARC encodes the Duffy blood group antigen, which is known to be adaptive with respect”
BackgroundJiang, L., Duriseti, S., Sun, P. D., & Miller, L. H. (2009) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2009.06.006 · Cited by 27
Belsito, A., Costa, D., Fiorito, C., Iorio, G. D., Casamassimi, A., Perrotta, S., & Claudio Napoli, A. (2014) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2014.12.006 · Cited by 26
“The Duffy silencing mutation (-67T>C) in the GATA box at the promoter region inhibits the expression of Duffy glycoprotein in the erythrocytes while preserving the expression of both Fya and Fyb in other tissues [28].”
BackgroundCARTRON, J. (1996) · Transfusion Clinique et Biologique · doi:10.1016/s1246-7820(96)80036-x · Cited by 25
Self-citationAtypical chemokine receptors in cancer
Samus, M., & Rot, A. (2024) · Cytokine · doi:10.1016/j.cyto.2024.156504 · Cited by 28
Weppelmann, T. A., Carter, T. E., Zhongsheng, C., von Fricken, M. E., Victor, Y. S., Existe, A., & Okech, B. A. (2013) · Malaria Journal · doi:10.1186/1475-2875-12-30 · Cited by 26
de Sousa, T. N., Sanchez, B. A. M., Cerávolo, I. P., de Carvalho, L. H., & de Brito, C. F. A. (2007) · Vox Sanguinis · doi:10.1111/j.1423-0410.2007.00902.x · Cited by 25
Nickel, R., Willadsen, S. A., Freidhoff, L. R., Huang, S.-K., Caraballo, L. R., Naidu, R. P., Levett, P. N., Blumenthal, M., Banks-Schlegel, S. P., Bleecker, E. R., et al. (1999) · Human Immunology · doi:10.1016/s0198-8859(99)00039-7 · Cited by 25
Blood group genotype analysis for the quality improvement of reagent test red blood cells
Hult, A. K., Hellberg, Å., Wester, E. S., Olausson, P., Storry, J. R., & Olsson, M. L. (2005) · Vox Sanguinis · doi:10.1111/j.1423-0410.2005.00623.x · Cited by 26
Duffy blood group system genotyping in an urban Tunisian population
Sellami, M. H., Kâabi, H., Midouni, B., Dridi, A., Mojaat, N., Boukef, M. K., & Hmida, S. (2008) · Annals of Human Biology · doi:10.1080/03014460802082127 · Cited by 25
“The silent allele (FY*0) results from a GATA box mutation in the FY promoter (T-46C) disrupting a binding site for an erythroid transcription factor (Tournamille et al. 1995).”
BackgroundDavis, M. B., Walens, A., Hire, R. R., Mumin, K., Brown, A. M., Ford, D., Howerth, E. W., & Monteil, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140098 · Cited by 25
“We anticipated that the Fy- allele may facilitate removal of DARC/ACKR1expression from lymphocytes if the hematopoietic transcription factor (GATA-3), reported to be the regulator in erythrocytes [49], was also the regulator in lymphoblasts.”
BackgroundGunalan, K., Sá, J. M., Barros, R. R. M., Anzick, S. L., Caleon, R. L., Mershon, J. P., Kanakabandi, K., Paneru, M., Virtaneva, K. I., Martens, C., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1818485116 · Cited by 27
“Mutation in the GATA1 binding site in the upstream region of the gene encoding the Duffy antigen resulted in the loss of expression of the Duffy antigen on the surface of erythrocytes (6).”
BackgroundChiaroni, J., Touinssi, M., Frassati, C., Degioanni, A., Gibert, M., Reviron, D., Mercier, P., & Boëtsch, G. (2004) · Human Biology · doi:10.1353/hub.2004.0053 · Cited by 24
Yin, Q., Srivastava, K., Gebremedhin, A., Makuria, A. T., & Flegel, W. A. (2018) · Human Genome Variation · doi:10.1038/s41439-018-0024-8 · Cited by 24
Blood group genotyping in a population of highly diverse ancestry
Pellegrino, J., Castilho, L. M., Rios, M., & Souza, C. A. D. (2001) · Journal of Clinical Laboratory Analysis · doi:10.1002/1098-2825(2001)15:1 · Cited by 24
Fy x is associated with two missense point mutations in its gene and can be detected by PCR–SSP
Gassner, C., Kraus, R., Drnovšek, T. D., Kilga‐Nogler, S., Utz, I., MUELLER, T. H., Schunter, F., & Schoenitzer, D. (2000) · Immunohematology · doi:10.21307/immunohematology-2019-579 · Cited by 24
Human determinants of age-dependent patterns of death from infection
Abel, L., & Casanova, J. (2024) · Immunity · doi:10.1016/j.immuni.2024.05.020 · Cited by 26
“45 Heterozygosity for HbAS also provides 10-fold protection against severe forms of P. falciparum malaria.”
BackgroundAssociation of Duffy Blood Group Gene Polymorphisms with IL8 Gene in Chronic Periodontitis
Sippert, E., Silva, C. O., Visentainer, J. E. L., & Sell, A. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083286 · Cited by 23
“The -67T>C SNP in the 5 ́ untranslated region of the FY gene, resulting in the absence of Fyb from RBCs and eliciting the Fy(b-) phenotype, does not change the expression of this protein in other tissues [13].”
BackgroundWhite blood cell ranges and frequency of neutropenia by Duffy genotype status
Bagheri, M., Chung, C. P., Dickson, A. L., Driest, S. L. V., Borinstein, S. C., & Mosley, J. D. (2022) · Blood Advances · doi:10.1182/bloodadvances.2022007680 · Cited by 23
The impact of cis-acting polymorphisms on the human phenotype
Jones, B. L., & Swallow, D. M. (2011) · The HUGO Journal · doi:10.1007/s11568-011-9155-4 · Cited by 30
“Although many of these variants affect protein sequences, one of these mutations is a cis-acting regulatory mutation that disrupts the binding of the GATA1 transcription factor, preventing the expression of the Duffy blood group chemokine receptor (DARC) in erythrocytes (Tournamille et al. 1995).”
BackgroundFineMAV: prioritizing candidate genetic variants driving local adaptations in human populations
Szpak, M., Mezzavilla, M., Ayub, Q., Chen, Y., Xue, Y., & Tyler‐Smith, C. (2018) · Genome biology · doi:10.1186/s13059-017-1380-2 · Cited by 25
How well do we understand the basis of classic selective sweeps in humans?
Szpak, M., Xue, Y., Ayub, Q., & Tyler‐Smith, C. (2019) · FEBS Letters · doi:10.1002/1873-3468.13447 · Cited by 25
Different inactivating mutations in theLUgenes of three individuals with the Lutheran‐null phenotype
Crew, V. K., Mallinson, G., Green, C. A., Poole, J., Uchikawa, M., Tani, Y., Geisen, C., Oldenburg, J., & Daniels, G. L. (2007) · Transfusion · doi:10.1111/j.1537-2995.2006.01141.x · Cited by 23
“It is important to ascertain, however, the molecular background to this rare phenotype to understand whether it is likely that the Lu-glycoproteins are absent throughout the body in these individuals or whether the deficiency is restricted to erythroid cells, as occurs in the most common type of the null phenotype of…”
BackgroundMicrosatellite Variation and Evolution of the Human Duffy Blood Group Polymorphism
Seixas, S., Ferrand, N., & Rocha, J. (2002) · Molecular Biology and Evolution · doi:10.1093/oxfordjournals.molbev.a004003 · Cited by 25
The link between chromatin structure protein acetylation and cellular differentiation
Sartorelli, V. (2001) · Frontiers in bioscience · doi:10.2741/a665 · Cited by 30
Human Genomics of COVID-19 Pneumonia: Contributions of Rare and Common Variants
Cobat, A., Zhang, Q., Effort, C. H. G., Abel, L., Casanova, J., & Fellay, J. (2023) · Annual Review of Biomedical Data Science · doi:10.1146/annurev-biodatasci-020222-021705 · Cited by 27
“…that modifies the GATA-1 binding site in the DARC promoter, thereby selectively preventing the expression of the Duffy antigen on red blood cells (94); [B] HIV-1, conferred by a 32 bp deletion in CCR5, the gene encoding the main HIV-1 coreceptor on CD4 + T cells (95–97); and [C] norovirus, due…”
BackgroundHost Genetic Factors in Resistance and Susceptibility to Malaria
Kwiatkowski, D. P., & Luoni, G. (2014) · ASM Press eBooks · doi:10.1128/9781555817558.ch24 · Cited by 22
Mange, K. C., Prak, E. T. L., Kamoun, M., Du, Y., Goodman, N. G., Danoff, T. M., Hoy, T., Newman, M., Joffe, M. M., & Feldman, H. I. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00871.x · Cited by 22
“This single nucleotide polymorphism (SNP) disrupts transcription of the gene [14].”
BackgroundПономаренко, П. М., Ponomarenko, M. P., Drachkova, I. A., Lysova, M. V., Arshinova, T. V., Savinkova, L. K., & Kolchanov, N. A. (2009) · Molecular Biology · doi:10.1134/s0026893309030157 · Cited by 24
“The malarian parasite Plasmodium vivax uses this chemokine receptor to invade erythrocytes and cause malaria [58].”
BackgroundChristensen, R. D., Bahr, T. M., Ilstrup, S. J., & Dizon‐Townson, D. (2023) · Journal of Perinatology · doi:10.1038/s41372-023-01785-3 · Cited by 21
“This change disrupts the promotor resulting in complete loss of the Duffy antigen on the erythrocyte surface [69].”
BackgroundFichou, Y., Berlivet, I., Richard, G., Tournamille, C., Castilho, L. M., & Férec, C. (2019) · Transfusion Medicine and Hemotherapy · doi:10.1159/000504584 · Cited by 23
Self-citationEvolution and Genetic Architecture of Chromatin Accessibility and Function in Yeast
Connelly, C. F., Wakefield, J. C., & Akey, J. M. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004427 · Cited by 26
“chemokine receptor on malaria resistance in humans [10], [11]”
BackgroundDuffy blood group system and the malaria adaptation process in humans
de Carvalho, G. B., & de Carvalho, G. B. (2011) · Revista Brasileira de Hematologia e Hemoterapia · doi:10.5581/1516-8484.20110016 · Cited by 43
“(35) In blacks it was shown to be due to a mutation at position -33 (T>C) in the promoter region of the FYB gene, the GATA-box.”
BackgroundInfluentialCavasini, C. E., de Mattos, L. C., Alves, R. T., Couto, Á. A. R. D., Calvosa, V. S. P., Bonini-Domingos, C. R., Castilho, L. M., Rossit, A. R. B., & Machado, R. L. D. (2006) · Human Biology · doi:10.1353/hub.2006.0034 · Cited by 21
“…we acknowledge is related to the fact that, by using blood group phenotyping, we were not able to assess molecular changes, because alterations such as gene promoter disruption or deletion can abolish or reduce antigen expression (Tournamille et al. 1995; Michon et al. 2001; Storry et al. 2001).”
BackgroundDuffy antigen is expressed during erythropoiesis in Duffy-negative individuals
Dechavanne, C., Dechavanne, S., Bosch, J., Métral, S., Redinger, K. R., Watson, Q. D., Ratsimbasoa, A. C., Roeper, B., Krishnan, S., Fong, R., et al. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.10.019 · Cited by 22
Self-citationChaumier, T., Yang, F., Manirakiza, E., Aït-Mohamed, O., Wu, Y., Chandola, U., Jesus, B., Piganeau, G., Groisillier, A., & Tirichine, L. (2024) · ISME Communications · doi:10.1093/ismeco/ycad008 · Cited by 21
“For instance, LOF mutations at the 5 or 3 regions of genes may not entirely abolish their functions, and truncated proteins resulting from such mutations could act as dominant-negative factors [69, 70].”
Lopez, G. H., Morrison, J., Condon, J. C., Wilson, B., Martin, J. R., Liew, Y., Flower, R. L., & Hyland, C. A. (2015) · Vox Sanguinis · doi:10.1111/vox.12273 · Cited by 20
Emerging strategies of blood group genotyping for patients with hemoglobinopathies
Belsito, A., Magnussen, K., & Napoli, C. (2016) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2016.11.007 · Cited by 24
Adams, J. H., Ntumngia, F. B., Thomson-Luque, R., & Pires, C. V. (2016) · Journal of Receptor Ligand and Channel Research · doi:10.2147/jrlcr.s99725 · Cited by 25
“The feasibility of this approach is supported by existing evidence pointing to resistance of RBCs of naturally selected Duffy-negative blacks to P. vivax infection 10 and the fact that DARC negativity will have no adverse effect on human health.”
InfluentialChemokines and their receptors in infectious disease
McDermott, D. H., & Murphy, P. M. (2000) · Springer Seminars in Immunopathology · doi:10.1007/s002810000052 · Cited by 20
“The Duffy-negative phenotype is due to a single nucleotide mutation in a GATA-1 site in the promoter that eliminates transcription specifically in the erythroid lineage [105].”
BackgroundTransfusion medicine and molecular genetic methods
Edinur, H. A., Saleh, R. A., Zulkafli, Z. B., Mat, N. F. C., & Chambers, G. K. (2018) · International Journal of Preventive Medicine · doi:10.4103/ijpvm.ijpvm_232_16 · Cited by 21
“The fourth phenotype Fy (a−b−) or FybEs (erythroid silent) is due to a 67T>C point mutation in the GATA‐1‐binding motif of the FY*B promoter.[91,93] Despite having an apparent FybEs phenotype, several individuals do express weak Fyb antigens (Fya‐bweak) which are associated with FY*X allele.”
BackgroundAlloimmunity to Human Red Blood Cell Antigens
Urbaniak, S. J. (2002) · Vox Sanguinis · doi:10.1111/j.1423-0410.2002.tb05321.x · Cited by 19
“…there is a partial gene deletion of FY, whereas in Blacks there appears to be a down regulation of Fy glycoprotein synthesis due to failure of transcription in hemopoietic tissue (Mallinson et al 1995; Tournamille et al 1995), suggesting that immune peptide recognition and processing are different.”
BackgroundImportance of extended blood group genotyping in multiply transfused patients
Osman, N. H., Sathar, J., Leong, C. F., Zulkifli, N. F., Sabudin, R. Z. A. R., Othman, A., & Asnawi, A. W. A. (2017) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2017.03.009 · Cited by 19
Characterization of the phenotypic consequences of the Duffy-null genotype
Hysong, M. R., Shuey, M. M., Huffman, J. E., Auer, P. L., Reiner, A. P., & Raffield, L. M. (2025) · Blood Advances · doi:10.1182/bloodadvances.2024014399 · Cited by 27
“16,18,21 We used age at last phecode, sex at birth/gender (cisgender male, cis-gender female, and sex and/or gender minority), 10 genetic PCs, record depth, visit frequency, race (White, Black, Middle Eastern, >1 race, Asian, Unknown), and Hispanic ethnicity as covariates.”
Пономаренко, П. М., Suslov, V. V., Savinkova, L. K., Ponomarenko, M. P., & Kolchanov, N. A. (2010) · BIOPHYSICS · doi:10.1134/s0006350910030036 · Cited by 18
Transfusion and Cellular Therapy in Pediatric Sickle Cell Disease
Zheng, Y., & Chou, S. T. (2020) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2020.10.007 · Cited by 23
Zoonotic Transmission and Host Switches of Malaria Parasites
Su, X., & Wu, J. (2021) · Zoonoses · doi:10.15212/zoonoses-2021-0015 · Cited by 30
“An amino acid substitution in the GATA-1 transcription factor binding site of the gene encoding the Duffy blood group, Fy, causes an absence of DARC expression [60].”
BackgroundMolecular Bases and Genotyping for Rare Blood Types
Jungbauer, C. (2009) · Transfusion Medicine and Hemotherapy · doi:10.1159/000214430 · Cited by 18
Erythrocyte binding ligands in malaria parasites: Intracellular trafficking and parasite virulence
Culleton, R. L., & Kaneko, O. (2009) · Acta Tropica · doi:10.1016/j.actatropica.2009.10.025 · Cited by 18
“The FY*Bnull allele carries a single nucleotide mutation which impairs promoter activity by disrupting a binding site for the h-GATA-1 erythroid transcription factor (Tournamille et al., 1995).”
BackgroundHu, S.-Y., Liu, T., Liu, Z., Ledet, E., Velasco-Gonzalez, C., Mandal, D., & Koochekpour, S. (2010) · Asian Journal of Andrology · doi:10.1038/aja.2010.5 · Cited by 17
da Costa, D. C., Schinaider, A. A., dos Santos, T. M., Schörner, E. J., Simon, D., Maluf, S. W., de Moraes, A. C. R., & Santos‐Silva, M. C. (2016) · Revista Brasileira de Hematologia e Hemoterapia · doi:10.1016/j.bjhh.2016.04.005 · Cited by 18
Induction of Duffy gene (FY) in human endothelial cells and in mouse
Chaudhuri, A. (2003) · Cytokine · doi:10.1016/s1043-4666(03)00033-4 · Cited by 18
Heritability of P. falciparum and P. vivax Malaria in a Karen Population in Thailand
Phimpraphi, W., Paul, R. E. L., Witoonpanich, B., Turbpaiboon, C., Peerapittayamongkol, C., Cheepsunthorn, C. L., Casadémont, I., Tungpradabkul, S., Krudsood, S., Kaewkunwal, J., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003887 · Cited by 20
“However, emergence of the same null allele mutation (T-46C) [23] but on a different haplotype was reported in Papua New Guinea and which affects expression of the Duffy blood group [35] and leads to reduced P. vivax erythrocyte infection [36].”
BackgroundMethodInfluentialMolecular approaches to blood group identification
Reid, M. E., & Lomas, C. (2002) · Current Opinion in Hematology · doi:10.1097/00062752-200203000-00012 · Cited by 18
Cloning and genetic characterization of blood group carrier molecules and antigens
Lögdberg, L., Reid, M. E., & Miller, J. L. (2002) · Transfusion Medicine Reviews · doi:10.1053/tmrv.2000.29347 · Cited by 18
Jinna, N., Rida, P. C. G., Su, T., Gong, Z., Yao, S., LaBarge, M. A., Natarajan, R. D., Jovanović‐Talisman, T., Ambrosone, C. B., & Seewaldt, V. L. (2022) · Cells · doi:10.3390/cells11233818 · Cited by 22
“This DARC promoter mutation is known as the “duffy-null allele” [13,16,17].”
BackgroundEvolutionary history of regulatory variation in human populations
Lappalainen, T., & Dermitzakis, E. T. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq406 · Cited by 19
Cross-reactivity of antibodies to human and primate red cell antigens
Blancher, A., Reid, M. E., & Socha, W. W. (2000) · Transfusion Medicine Reviews · doi:10.1016/s0887-7963(00)80006-1 · Cited by 17
Souza-Silva, F. A., Torres-Martínez, L. M., Alves, J. R. S., Tang, M. L., Sanchez, B. A. M., de Sousa, T. N., Fontes, C. J. F., Nogueira, P. A., Rocha, R. S., de Brito, C. F. A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093782 · Cited by 18
Duffy Blood Group Genotyping in Thai Blood Donors
Nathalang, O., Intharanut, K., Siriphanthong, K., Nathalang, S., & Kupatawintu, P. (2015) · Annals of Laboratory Medicine · doi:10.3343/alm.2015.35.6.618 · Cited by 17
“-33T>C causes a non-expression antigen in FY-negative individuals [11-13].”
BackgroundHuman PTCHD3 nulls: rare copy number and sequence variants suggest a non-essential gene
Seno, M. M. G., Kwan, B. Y., Lee-Ng, K. K. M., Moessner, R., Lionel, A. C., Marshall, C. R., & Scherer, S. W. (2011) · BMC Medical Genetics · doi:10.1186/1471-2350-12-45 · Cited by 21
“For example, it is reported that homozygous mutations affecting DARC or CCR5 result in resistance to certain categories of malaria [13] or AIDS [14,15], respectively, without posing any overt deleterious effect on the individuals carrying these mutations.”
BackgroundHemolytic Disease of the Fetus and Newborn
Ross, M. B., & de Alarcón, P. A. (2013) · NeoReviews · doi:10.1542/neo.14-2-e83 · Cited by 18
Duffy blood group genotypes among malaria patients in Rondônia, Western Brazilian Amazon
Cavasini, C. E., Pereira, F. J. T., Ribeiro, W. L., Wunderlich, G., & Ferreira, M. U. (2001) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/s0037-86822001000600016 · Cited by 17
Li, J., Iwamoto, S., Sugimoto, N., Okuda, H., & Kajii, E. (1997) · Human Genetics · doi:10.1007/s004390050408 · Cited by 17
Tournamille, C. (2000) · Transfusion Clinique et Biologique · doi:10.1016/s1246-7820(00)80038-5 · Cited by 17
Self-citationde Brevern, A. G., Autin, L., Colin, Y., Bertrand, O., & Etchebest, C. (2009) · Infectious Disorders - Drug Targets · doi:10.2174/1871526510909030289 · Cited by 19
Self-citationKlein, H. G., & FMedSci, D. J. A. P. F. (2005) · Wiley eBooks · doi:10.1002/9780470986868.ch6 · Cited by 17
Resolving the Variable Genome and Epigenome in Human Disease
Knight, J. C. (2012) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2011.02508.x · Cited by 17
Variation and impact of polygenic hematologic traits in monogenic sickle cell disease
Pincez, T., Lo, K. S., D'Orengiani, A.-L. P. H. D., Garrett, M. E., Brugnara, C., Ashley‐Koch, A. E., Telen, M. J., Galactéros, F., Joly, P., Bartolucci, P., et al. (2022) · Haematologica · doi:10.3324/haematol.2022.281180 · Cited by 20
“36 It has been known for some time that the Duffy/ DARC null variant is strongly associated with lower circulating neutrophil and WBC counts in SCD and non-SCD individuals due to extravasation to tissues, 31,37,38 and in particular the spleen.”
Lopez, G. H., Condon, J. C., Wilson, B., Martin, J. R., Liew, Y., Flower, R. L., & Hyland, C. A. (2014) · Vox Sanguinis · doi:10.1111/vox.12185 · Cited by 17
Rising report of Plasmodium vivax in sub-Saharan Africa: Implications for malaria elimination agenda
Oboh, M. A., Oyebola, K. M., Idowu, E. T., Badiane, A. S., Otubanjo, O. A., & Ndiaye, D. (2020) · Scientific African · doi:10.1016/j.sciaf.2020.e00596 · Cited by 16
MEZCLA GENICA Y LINAJES UNIPARENTALES EN COMODORO RIVADAVIA (PROVINCIA DE CHUBUT, ARGENTINA)
Avena, S. A., Parolín, M. L., Dejean, C. B., Part, M. C. R., Fabrykant, G., Goicoechea, A. S., Dugoujon, J., & Carnese, F. R. (2009) · Revista Argentina de Antropología Biológica · Cited by 15
Host Receptors in Malaria Merozoite Invasion
Oh, S. S., & Chishti, A. H. (2005) · Springer eBooks · doi:10.1007/3-540-29088-5_8 · Cited by 17
Dechavanne, C., Dechavanne, S., Métral, S., Roeper, B., Krishnan, S., Fong, R., Bennett, S., Carias, L. L., Chen, E., Salinas, N. D., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/508481 · Cited by 16
Self-citationPower of inclusion: Enhancing polygenic prediction with admixed individuals
Tanigawa, Y., & Kellis, M. (2023) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2023.09.013 · Cited by 20
“The UTR variant rs2814778 disrupts binding sites of the GATA1 transcription factor and shuts down expression of the receptor in erythrocytes; 66 thus, it is considered the null allele.”
Background
Metadata
- Authors
- Tournamille, C., Colin, Y., Cartron, J. P., & Le Van Kim, C.
- Affiliations
- Inserm (FR)
- Venue
- Nature Genetics
- Published
- 1995-06
- Volume
- 10
- Issue
- 2
- Pages
- 224-228
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2080491517
- Cited by
- 741
- References
- 32
- Citations by year
- 2026: 15 · 2025: 14 · 2024: 23 · 2023: 28 · 2022: 20 · 2021: 28 · 2020: 27 · 2019: 23 · 2018: 22 · 2017: 27 · 2016: 21 · 2015: 22 · 2014: 25 · 2013: 33 · 2012: 25
- FWCI
- 20.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Hematology › Blood groups and transfusion
- Keywords
- Duffy blood group system, promoter mutations, erythroid gene expression, Plasmodium vivax, chemokine receptors, single-exon genes, African Americans
- MeSH terms
- Antigens, Protozoan, Base Sequence, Carrier Proteins, Chromosome Mapping, DNA-Binding Proteins, Duffy Blood-Group System, Erythrocytes, Genotype, Humans, Molecular Sequence Data, Mutation, Promoter Regions, Genetic, Receptors, Cell Surface, Transcription Factors, Transcription, Genetic, Tumor Cells, Cultured, Protozoan Proteins, Gene Expression, Black People, Erythroid-Specific DNA-Binding Factors, GATA1 Transcription Factor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.